7 Results for "

8-Pcpt-cGMP

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "8-Pcpt-cGMP" in MCE Product Catalog:

Cat. No.: HY-137016
CAS No.: 54364-02-2
Target:  

HCN Channel

Research Areas:  

Neurological Disease

8-Pcpt-cGMP is an agonist for cyclic nucleotide-gated (CNG) channel with an EC50 of 0.5 μM. 8-Pcpt-cGMP exhibits good membrane permeability. 8-Pcpt-cGMP can be used in studies about the function of CNG channels in visual signal transduction and olfactory transduction .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-137016A
CAS No.: 51239-26-0
Purity:  ≥99.0%
Target:  

HCN Channel

Research Areas:  

Neurological Disease

8-Pcpt-cGMP sodium is the sodium salt form of 8-Pcpt-cGMP (HY-137016). 8-Pcpt-cGMP sodium is an agonist for cyclic nucleotide-gated (CNG) channel with an EC50 of 0.5 μM. 8-Pcpt-cGMP sodium exhibits good membrane permeability. 8-Pcpt-cGMP sodium can be used in studies about the function of CNG channels in visual signal transduction and olfactory transduction .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110221
CAS No.: 208445-07-2
Target:  

PKG

Research Areas:  

Neurological Disease

Rp-8-pCPT-cGMPS sodium is the sodium salt form of Rp-8-pCPT-cGMPS. Rp-8-pCPT-cGMPS is an inhibitor for cGMP-dependent protein kinase (cGK). Rp-8-pCPT-cGMPS sodium is an agonist for cyclic nucleotide-gated (CNG) channels in a voltage-dependent manner .
loading...
    loading...
Cat. No.: HY-134345
CAS No.: 272445-72-4
Synonyms: 8-(4-Chlorophenylthio)-cGMP-AM
Target:  

PKG

Research Areas:  

Neurological Disease

8-pCPT-cGMP-AM (8-(4-Chlorophenylthio)-cGMP-AM) is a highly membrane permeable prodrug of the PKG agonist 8-pCPT-cGMP, which increases the membrane permeability of cGMP and is converted to its active form by esterase hydrolysis within the cell, thereby activating PKG. 8-pCPT-cGMP-AM can be used to explore the role of cGMP signaling in neural plasticity and memory formation .
loading...
    loading...
Cat. No.: HY-137108
CAS No.: 160385-87-5
Target:  

PKA PKG

Research Areas:  

Neurological Disease

Sp-8-pCPT-cGMPS is a potent cyclic guanosine monophosphate-gated channel agonist and a lipophilic activator of protein kinase G (types I α, I β, and II) and protein kinase A type II with excellent cell membrane permeability and phosphodiesterase stability. Sp-8-pCPT-cGMPS can be used to study the role of cGMP in neural plasticity and synaptic transmission .
loading...
    loading...
Cat. No.: HY-137373
CAS No.: 153660-04-9
Target:  

PKG

Research Areas:  

Others

Rp-8-pCPT-cGMPS is a competitive inhibitor of cGMP-dependent protein kinase (PKG) (Ki=0.5 μM). Rp-8-pCPT-cGMPS has high lipid solubility and can more easily penetrate the cell membrane and reach sufficient concentration inside the cell to inhibit cGMP-dependent protein kinase. Rp-8-pCPT-cGMPS can be used to study the activity and function of cGMP-dependent protein kinase in platelets .
loading...
    loading...
Cat. No.: HY-137633
CAS No.: 172806-21-2
Target:  

PKG

Research Areas:  

Neurological Disease

Sp-8-Br-PET-cGMPS is a membrane-permeable PKG agonist and a membrane-permeable inhibitor of retinal-type cGMP-gated ion channels, as well as an activator of cGMP-dependent protein kinases I α and I β. Sp-8-Br-PET-cGMPS is resistant to mammalian cyclic nucleotide-dependent phosphodiesterases, has no metabolic side effects, and is more lipophilic and permeable than Sp-8-pCPT-cGMPS. Sp-8-Br-PET-cGMPS can be used to study the role of cGMP signaling pathways in the nervous system .
loading...
    loading...